Chemomab Therapeutics Ltd. Additional Paid in Capital
Chemomab Therapeutics Ltd. (CMMB) had Additional Paid in Capital of $70.59 million as of 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Notes
ifrs-full:AdditionalPaidinCapital · last filed 2019-04-24
- 2018-12-31: Additional Paid in Capital $70.59M.
- 2017-12-31: Additional Paid in Capital $60.04M.
| Period end | Additional Paid in Capital |
|---|---|
| 2018-12-31 | $70.59M 20-F · filed 2019-04-24 |
| 2017-12-31 | $60.04M 20-F · filed 2019-04-24 |